Transcatheter aortic valve replacement: A potential option for the nonsurgical patient

Clinical Cardiology

Volumn 32, Issue 6, 2009, Pages 296-301

  Patel, Jigar H ^a   Mathew, Sunil T ^b   Hennebry, Thomas A ^b,c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; AORTA VALVE; AORTA VALVE REPLACEMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; EXPERIENCE; HEART CATHETER; HEART PACING; HUMAN; LEARNING; OUTCOME ASSESSMENT; REVIEW; SAFETY; TRANSCATHETER AORTIC VALVE REPLACEMENT;

ALGORITHMS; AORTIC VALVE STENOSIS; CLINICAL COMPETENCE; EVIDENCE-BASED MEDICINE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN; TIME FACTORS; TREATMENT OUTCOME;

EID: 67650562309     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20535     Document Type: Review

References (29)

1. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630-634.
2. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005-1011. (Pubitemid 44353666)
3. US Census Bureau. US Interim Projections by Age, Sex, Race, and Hispanic Origin. In 2004.
4. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl JMed. 1999;341(3):142-147. (Pubitemid 29325741)
5. TarantiniG, Buja P, Scognamiglio R, et al. Aortic valve replacement in severe aortic stenosis with left ventricular dysfunction: determinants of cardiac mortality and ventricular function recovery. Eur J Cardiothorac Surg. 2003;24(6):879-885. (Pubitemid 37476362)
6. Murphy ES, Lawson RM, Starr A, Rahimtoola SH. Severe aortic stenosis in patients 60 years of age or older: left ventricular function and 10-year survival after valve replacement. Circulation. 1981;64(2 pt 2): II184-II188.
7. Connolly HM, Oh JK, Orszulak TA, et al. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Prognostic indicators. Circulation. 1997;95(10):2395-2400. (Pubitemid 27224734)
8. Kvidal P, Bergstrom R, Horte LG, Stahle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol. 2000;35(3):747-756. (Pubitemid 30167033)
9. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26(24):2714-2720. (Pubitemid 41746694)
10. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43(4):698-703. (Pubitemid 38229547)
11. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation. 2006;114(15):1616-1624. (Pubitemid 44547432)
12. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50(1):69-76. (Pubitemid 46970878)
13. Chiam P, Ruiz C. Percutaneous transcatheter aortic valve implantations: assessing results, judging outcomes, and planning trials. JACC: Cardiovasc Interv. 2008;1(4):341-350.
14. Buellesfeld L, Gerckens U, Grube E. Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter Cardiovasc Interv. 2008; 71(5):579-584. (Pubitemid 351550389)
15. Low RI BS, Yeo KK, Ebner A. Direct flow medical percutaneous aortic valve: proof of concept. Eurointervention. 2008;4:256-261.
16. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation. 2006;114(6):591-596. (Pubitemid 44202060)
17. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113(6):842-850. (Pubitemid 43754305)
18. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47(6):1214-1223.
19. Webb JG, Pasupati S, Achtem L, Thompson CR. Rapid pacing to facilitate transcatheter prosthetic heart valve implantation. Catheter Cardiovasc Interv. 2006;68(2):199-204. (Pubitemid 44167668)
20. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116(7):755-763. (Pubitemid 47255993)
21. Ye J, Cheung A, Lichtenstein SV, et al. Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg. 2007;31(1):16-21. (Pubitemid 44880770)
22. Pasupati S, Humphries K, AlAli A, et al. Abstract 1700: Balloon Expandable Aortic Valve [BEAV] Implantation. The first 100 Canadian patients. Circulation. Oct 2007; 116: II-357.
23. Svensson LG, Dewey T, Kapadia S, et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg. 2008;86(1):46-55.
24. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation. 2007;116(suppl 11): I240-I245. (Pubitemid 47480797)
25. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008;29(11): 1463-1470. (Pubitemid 351806497)
26. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16(1):9-13. (Pubitemid 29336425)
27. Shroyer AL, Coombs LP, Peterson ED, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75(6):1856-1865. (Pubitemid 36677229)
28. Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, Taylor KM. Generic, simple risk stratification model for heart valve surgery. Circulation. 2005;112(2):224-231. (Pubitemid 40982305)
29. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48(3):e1-e148.